Mar 03,2021 03:00 PM
Biocon, Divis Lab and Cadila also gain over 1% to support the sector. Alkem Lab shed over 2.5% to drag the sector.
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||612.25||50.01||148,434.86||555.55||0.65||3,366.01||106.10|
|Divis Laboratories Ltd||3,523.65||50.77||94,355.50||461.24||0.45||1,656.48||313.47|
|Dr Reddys Laboratories Ltd||4,518.45||31.99||76,070.87||443.70||0.55||3,397.50||979.36|
|Aurobindo Pharma Ltd||866.40||17.18||51,240.33||740.51||0.34||3,701.14||246.88|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Sun Pharmaceutical Industries Limited including its subsidiaries and associates (Sun Pharma) is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectru... More
Reports by sun-pharmaceuticals-industries-ltd-share-price
Mar 05, 2021
Sun Pharmaceuticals (Sun Pharma), India’s largest pharma company by revenue is making slow progress in its US specialty business which is unlikely to negate pricing pressure in generic business; rec...More
Mar 05, 2021 10:29 AM
The company’s consolidated revenue stood at Rs8,259.30cr, up 15.7% yoy and 17.2% qoq.
29 Jan 2021
09 Feb 2021
The Board at its meeting held today, declared an interim dividend of Rs. 5.50/- (Rupees Five and pai... More
29 Jan 2021
04 Jan 2021
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the... More